Literature DB >> 18518937

Serine/threonine kinase, Cot/Tpl2, regulates renal cell apoptosis in ischaemia/reperfusion injury.

Takaaki Yaomura1, Naotake Tsuboi, Yoshinori Urahama, Akinori Hobo, Kenji Sugimoto, Jun Miyoshi, Tetsuya Matsuguchi, Kannagi Reiji, Seiichi Matsuo, Yukio Yuzawa.   

Abstract

AIM: Cot/Tpl2, a serine/threonine (Ser/Thr) protein kinase, has been classified as a member of the mitogen-activated protein kinase (MAPK) family, and is known to have a pleiotropic role. Many studies have reported the involvement of Cot/Tpl2, mainly as a member of the Toll-like receptor (TLR) 4 signalling pathway in lipopolysaccharide (LPS)-induced tumor necrosis factor-alpha (TNF-alpha) production. At the same time, it is also related to the caspase-dependent apoptotic pathway. Thus, the role of Cot/Tpl2 in ischaemia/reperfusion injury (IRI) in which TNF-alpha and apoptosis are the major pathogenetic factors was studied.
METHODS: IRI was induced in wild type (Cot/Tpl2(+/+)) mice and in Cot/Tpl2-deficient (Cot/Tpl2(-/-)) mice. The extent of tubular injury and renal function were studied. TNF-alpha production, neutrophil infiltration and apoptosis were also compared between the two groups.
RESULTS: Cot/Tpl2(-/-) mice had preserved renal function compared with wild type mice in IRI. Although Cot/Tpl2 was phosphorylated in IRI and in the cultured tubular epithelial cells (TEC) after stimulation with LPS and hydrogen peroxide, there were no significant differences in terms of TNF-alpha production, neutrophil infiltration or MAPK activation between Cot/Tpl2(+/+) and Cot/Tpl2(-/-) mice. In contrast, Cot/Tpl2(-/-) mice showed obviously reduced terminal deoxynucleotidyl transferase-mediated dUTP nick end labelling positive cells and cleaved caspase-3 positive cells. Furthermore, Cot/Tpl2-deficient TECs demonstrated significantly less caspase-3 activation after hydrogen peroxide stimulation with comparable caspase-9 activation to wild type TEC.
CONCLUSION: Cot/Tpl2 did not function as a member of MAPK family, but as a promoter of apoptosis in IRI. These results suggest that Cot/Tpl2 could be a possible therapeutic target in IRI.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18518937     DOI: 10.1111/j.1440-1797.2008.00959.x

Source DB:  PubMed          Journal:  Nephrology (Carlton)        ISSN: 1320-5358            Impact factor:   2.506


  6 in total

1.  7,3',4'-Trihydroxyisoflavone, a metabolite of the soy isoflavone daidzein, suppresses ultraviolet B-induced skin cancer by targeting Cot and MKK4.

Authors:  Dong Eun Lee; Ki Won Lee; Sanguine Byun; Sung Keun Jung; Nury Song; Sung Hwan Lim; Yong-Seok Heo; Jong Eun Kim; Nam Joo Kang; Bo Yeon Kim; G Tim Bowden; Ann M Bode; Hyong Joo Lee; Zigang Dong
Journal:  J Biol Chem       Date:  2011-03-04       Impact factor: 5.157

2.  Suppression of mitochondrial biogenesis through toll-like receptor 4-dependent mitogen-activated protein kinase kinase/extracellular signal-regulated kinase signaling in endotoxin-induced acute kidney injury.

Authors:  Joshua A Smith; L Jay Stallons; Justin B Collier; Kenneth D Chavin; Rick G Schnellmann
Journal:  J Pharmacol Exp Ther       Date:  2014-12-12       Impact factor: 4.030

3.  Dynamic transcriptomic analysis of Ischemic Injury in a Porcine Pre-Clinical Model mimicking Donors Deceased after Circulatory Death.

Authors:  Sebastien Giraud; Clara Steichen; Geraldine Allain; Pierre Couturier; Delphine Labourdette; Sophie Lamarre; Virginie Ameteau; Solenne Tillet; Patrick Hannaert; Raphael Thuillier; Thierry Hauet
Journal:  Sci Rep       Date:  2018-04-13       Impact factor: 4.379

4.  The protective effects of total paeony glycoside on ischemia/reperfusion injury in H9C2 cells via inhibition of the PI3K/Akt signaling pathway.

Authors:  Peihong Shen; Junfeng Chen; Min Pan
Journal:  Mol Med Rep       Date:  2018-07-30       Impact factor: 2.952

5.  Tumor progression locus 2 ablation suppressed hepatocellular carcinoma development by inhibiting hepatic inflammation and steatosis in mice.

Authors:  Xinli Li; Chun Liu; Blanche C Ip; Kang-Quan Hu; Donald E Smith; Andrew S Greenberg; Xiang-Dong Wang
Journal:  J Exp Clin Cancer Res       Date:  2015-11-11

6.  Inhibition of the MAP3 kinase Tpl2 protects rodent and human β-cells from apoptosis and dysfunction induced by cytokines and enhances anti-inflammatory actions of exendin-4.

Authors:  E M Varin; A Wojtusciszyn; C Broca; D Muller; M A Ravier; F Ceppo; E Renard; J-F Tanti; S Dalle
Journal:  Cell Death Dis       Date:  2016-01-21       Impact factor: 8.469

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.